22 results
8-K
EX-99.1
HEPA
Hepion Pharmaceuticals Inc
28 Jun 22
Departure of Directors or Certain Officers
9:46am
responsibility during his seven-year career at Gilead Sciences, most recently serving as Director and Head, Digital Innovation Customer Engagement
8-K
EX-99.1
ozkv1u6
16 Nov 21
Hepion Pharmaceuticals and FibroFind Announce Anti-Cancer Activity of CRV431 in a Nonclinical Liver Cancer Study
8:53am
8-K
EX-99.1
odv9 4fih9wsw
9 Jun 21
Hepion Pharmaceuticals to be Added to the Russell Microcap® Index
9:06am
8-K
EX-99.1
qen3hzaktwtt38b
27 Oct 20
Other Events
9:45am
8-K
EX-99.1
yk81 0w6h1oew6r
4 Dec 19
Hepion Pharmaceuticals Announces Canadian Research Team’s Academic Appointments
12:00am
8-K
EX-99.1
zz1cef07e 963zvgd022
31 Jul 19
Other Events
1:41pm
8-K
dm52flim010qg2v43
31 Jul 19
Other Events
1:41pm
8-K
EX-99.1
g5x jui5sak3zn
2 Jan 19
Regulation FD Disclosure
4:26pm
FWP
yir86bg5
5 Jun 18
Free writing prospectus
4:31pm
8-K
EX-99.1
9ati1dm1j 63bqj
29 May 18
ContraVir Pharmaceuticals to Present at 2018 BIO International Convention
4:29pm
8-K
hatrzxqu9lx tmnyjhwg
29 May 18
ContraVir Pharmaceuticals to Present at 2018 BIO International Convention
4:29pm
10-KT
cff90u3stvl25xdc97c
26 Mar 18
Annual report (with FYE transition)
12:00am